Showing results (1-10 of 193) with videos related to
Sort By:
Pageof 20
Acta Oncologica (Stockholm, Sweden)|January 1, 1991
Positive margins: is adjunctive radiation therapy indicated?D F Paulson, C N RobertsonActa Oncologica (Stockholm, Sweden)|January 1, 1991
DNA in radical prostatectomy specimens. Prognostic value of tumor ploidyC N Robertson, D F PaulsonActa Oncologica (Stockholm, Sweden)|January 1, 1991
The relevance of stage A malignancy in prostatic cancerD F Paulson, C N RobertsonActa Oncologica (Stockholm, Sweden)|January 1, 1991
Radical surgery versus radiation therapy in early prostatic carcinomaC N Robertson, D F PaulsonThe Journal of Urology|May 1, 1985
Lethal complications of standard self-retaining ureteral stents in patients with ileal conduit urinary diversionP J Walther, C N Robertson, D F PaulsonWorld Journal of Urology|December 31, 1998
Peptidyl membrane-interactive molecules are cytotoxic to prostatic cancer cells in vitroC N Robertson, K M Roberson, A Pinero, et al.The Journal of Urology|November 20, 1997
Does prostate transitional cell carcinoma preclude orthotopic bladder reconstruction after radical cystoprostatectomy for bladder cancer?C E Iselin, C N Robertson, G D Webster, et al.Anticancer Research|February 19, 2002
Heat shock protein 70 (HSP70) does not prevent the inhibition of cell growth in DU-145 cells treated with TGF-beta1Y Ogawa, Y Nakagami, R Ishizaki, et al.Journal of the National Cancer Institute|July 21, 1993
Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancerD A Bell, J A Taylor, D F Paulson, et al.Surgical Oncology|August 1, 1994
Differential immunoreactivity of transforming growth factor alpha in benign, dysplastic and malignant prostatic tissuesC N Robertson, K M Roberson, A J Herzberg, et al.Pageof 20